IBS nomination committee

Report this content

Considering the shareholder composition of the company (the largest shareholder group, consisting of funds managed by Deccan Value Advisors L.P., holds shares representing almost 78 per cent of the votes in the company) and the fact that the company has been informed that the company’s largest shareholder group does not, taking into consideration its large majority, wish to participate in the work of the nomination committee but instead wishes to present its own proposal in connection with the annual general meeting, the establishment of a nomination committee has been deemed unnecessary. Thus, the company deviates from the rules on nomination committee that are contained in the Swedish Code on Corporate Governance.

Proposals regarding appointments of chairman at the annual general meeting, members of the board of directors, auditors as well as regarding remuneration to the members of the board of directors and the auditor will be made by the company’s largest shareholder group and presented in the notice for the annual meeting as well as on the company’s website. However proposals and opinions from the other shareholders are more than welcome. A shareholder that wishes to nominate a board member or wishes to contact a representative of the company’s largest shareholder group for some other reason may contact the chairman of the board of directors Dr. Pallab Chatterjee or alternatively CEO and President Mike Shinya.

For more information, please contact:
Oskar Ahlberg, Senior Vice President of Communications, IBS AB
Tel: +46-70-244 24 75
oskar.ahlberg@ibs.net


Documents & Links